What Are Intravenous Drugs?

The intravenous drug compounding center (Pharmacy Intravenous Admixture Services (PIVAS for short) refers to a prescription that is approved by a pharmacist under the operating environment that is in accordance with international standards and designed based on the characteristics of the drug. The specially trained pharmaceutical technicians strictly follow standard operating procedures. The configuration of intravenous drugs such as total intravenous nutrition, cytotoxic drugs, and antibiotics provides organizations with high-quality products and pharmaceutical services for clinical use.

Intravenous drug allocation center

Pharmacy Intravenous Admixture Services,

The Intravenous Drug Dispensing Center scattered the original area

The first is to change the traditional practice of mixing and preparing various clinical intravenous infusions and drugs. In the past, this practice was performed by nurses in the ward. Due to the limited environmental conditions in the ward, the quality of the infusion was easily affected, and patients

With the development of modern medical technology, the treatment mode of intravenous infusion of liquid drugs has been changed from open semi-open to fully closed infusion. In the world pharmaceutical industry,

Social Benefits of Intravenous Drug Allocation Center

PIVAS is a brand-new platform to promote the development of clinical pharmacy: pharmacists pass the examination prescription, rational drug design, participate in clinical rounds, collect information on adverse drug reactions (ADR), participate in the formulation of medication plans, and ensure the safety of medication;

PIVAS comprehensively improves the quality of clinical medical treatment: ensuring the quality of preparation and the safety of medication, and reducing the incidence of infusion reactions caused by clinical configuration to 0;

PIVAS comprehensively strengthened the occupational protection of medical personnel: realized the change of drug configuration from "exposed environment" to "clean environment", and completely solved the occupational protection problems such as cytotoxic drugs;

PIVAS can optimize resource allocation and realize resource sharing: it realizes the sharing of drug information, doctor's order information, and dispensing information, and through research and development of a safe medication firewall to prevent the occurrence of ADR. Centralized configuration can also achieve reasonable sharing of medicines and reasonable sharing of consumables;

PIVAS optimizes the allocation of human resources: saves nursing staff, "returns time to nurses, and returns nurses to patients". Free pharmacists from simple repetitive tasks such as simply issuing medicines and give full play to their respective professional advantages;

PIVAS strengthens hospital drug affairs management and deepens hospital reform: by promoting rational drug use, eliminating drug rebates, and providing a basis for the hospital to formulate a rational drug use policy, the average daily drug consumption and daily drug cost of patients are reduced by about 30% on average;

PIVAS has carried out in-depth risk control research and achieved comprehensive quality management: In response to the possible risks in each link of the PIVAS workflow, PIVAS has established and improved various rules and regulations from various aspects such as environmental quality, preparation process, personnel training, and operating standards. Operating procedures, personnel duties and rules, post duties and rules.

Economic benefits of intravenous drug allocation centers

Create economic benefits. The prices of Guangdong, Shanghai, Shandong, Yunnan, Heilongjiang and other places have approved the PIVAS preparation fee, 3 yuan for ordinary saline preparation, 5 yuan for antibiotics, 15 yuan for chemotherapy drugs, 20 yuan for nutritional drugs, and 1,500 beds per day. The configuration is more than 4,000 groups, and the daily income is more than 20,000;

Drug management has been strengthened, and the consistency rate of accounts has reached 100%. Drug failure and loss are zero, and contamination and damage are almost zero.

Reasonable sharing of medicines and consumables. Centralized configuration of the same variety is implemented to save disposable needles and other consumables.

Avoid medical disputes caused by the infusion reaction, and thus avoid direct loss of work, indirect economic loss and social impact. This part is incalculable.